Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06768827 · ClinicalTrials.gov registry record · NA
New Mechanisms of Obesity
A NA study of Insulin Resistance and Obesity and Overweight, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT06768827 is a NA study of Insulin Resistance and Obesity and Overweight that is actively recruiting participants, run by Yale University. The registered enrollment target is 55 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06768827, a NA study of Insulin Resistance and Obesity and Overweight, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in youth with obesity.
Conditions Studied
Interventions
- OTHER Lactulose Oral Product
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2025-11-13 |
| Est. Completion | 2030-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06768827
The ClinicalTrials.gov registry entry for NCT06768827 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (78% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Lactulose Oral Product is the first listed.
NCT06768827 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06768827 about?
NCT06768827 is a clinical study titled "New Mechanisms of Obesity". Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in yo...
What is the current status of trial NCT06768827?
This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2025-11-13. Estimated completion is 2030-03-31.
What conditions does trial NCT06768827 study?
This clinical trial studies the following conditions: Insulin Resistance, Obesity and Overweight, Obesity and Obesity-related Medical Conditions.
What interventions are being tested in trial NCT06768827?
The interventions under investigation include: Lactulose Oral Product (OTHER).
Who is sponsoring clinical trial NCT06768827?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06768827 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.